What is MediPocket USA, and how does it work?

MediPocket USA is a global health concierge service that connects international patients with top U.S. hospitals and healthcare providers. We facilitate access to advanced medical treatments, remote second opinions, and personalized care plans tailored to your specific health needs.

How can I access top U.S. hospitals through MediPocket USA?

MediPocket USA simplifies the process of accessing world-class healthcare in the U.S. by handling all logistics, from matching you with the best hospital and specialists for your condition to coordinating appointments and follow-ups.

What medical specialties do MediPocket USA offer access to?

We offer access to a wide range of medical specialties including oncology, cardiology, neurology, orthopedics, pediatrics, plastic surgery, transplants and more. Our network includes leading experts in these fields at top-ranked U.S. hospitals.

How do I start the process of getting a remote second opinion from U.S. doctors?

To get a remote second opinion, you simply need to submit your medical records through our secure platform. We will then connect you with a specialist in the U.S. who will review your case and provide a comprehensive opinion.

Can MediPocket USA help me obtain a medical visa for treatment in the U.S.?

Yes, MediPocket USA assists with the medical visa application process, ensuring all necessary documentation and information are submitted for a smooth visa approval.

Does MediPocket USA assist with travel arrangements and accommodations?

Yes, we assist with all aspects of your medical journey, including travel arrangements, accommodation bookings, and transportation services, ensuring a comfortable and stress-free experience.

How are treatment costs handled through MediPocket USA?

We provide transparent cost estimates before treatment and help you navigate payment options. Our team works with you to ensure that you are fully informed of all costs involved and any available financing options.

What types of health insurance are accepted by the hospitals MediPocket USA partners with?

The hospitals we work with accept a wide range of international health insurance plans. We can help verify if your insurance is accepted and discuss other payment options if necessary.

Are there language support services available for international patients?

Yes, we offer multilingual support services, including interpreters and translation of medical documents, to ensure that language barriers do not affect your care experience.

How does MediPocket USA ensure the quality of care I receive in the U.S.?

We partner with top-ranked U.S. hospitals and board-certified specialists to ensure that you receive the highest standard of care. Our rigorous selection process and ongoing partnerships guarantee access to the best medical expertise available.

Immunotherapy Treatment In The USA

Patients all across the world may now access it.

Immunotherapy therapies that are now unavailable in most countries are being administered at top US cancer centers. MediPocket USA links foreign patients to these programs, which are completely coordinated, physician-matched, and do not require US insurance.

Every case is physician-reviewed.

MD Anderson, MSK, Johns Hopkins, and Mayo Clinic

Checkpoint inhibitors, CAR-T, and cancer vaccines

Serving more than 21 countries and not requiring US residence

Why is the United States of America at the forefront of immunotherapy?

Immunotherapy is a cancer treatment that targets and eliminates cancer cells using the body’s immune system. Immunotherapy is intended to target cancer precisely, unlike chemotherapy, which targets all rapidly developing cells. For many patients, immunotherapy has far less systemic adverse effects.

Because it has the highest number of NCI-designated cancer centers, ongoing clinical trials, and FDA-approved immunotherapy procedures worldwide, the United States is at the forefront of immunotherapy development. Approved and available treatments in the United States are frequently two to five years ahead of those in other nations.

Immunotherapy options offered by leading US facilities:

Checkpoint inhibitors

Checkpoint inhibitors (PD-1, PD-L1, CTLA-4 inhibitors) are medications that eliminate the “off switch” cancer utilizes to evade the immune system.

CAR-T

CAR-T cell therapy involves reprogramming a patient’s own T cells to identify and eliminate cancerous cells.

Cancer vaccines

Cancer vaccines: customized shots based on the unique mutation profile of a tumor

Monoclonal antibodies

Monoclonal antibodies are synthetic proteins that identify cancer cells so the immune system can destroy them.

Immune-signaling

Immune-signaling proteins that boost the body’s anti-cancer response are known as cytokines.

Immune cells

Immune cells are removed, altered, and reinfused in greater quantities by adoptive cell transfer.

Who qualifies for Immunotherapy in the USA?

Immunotherapy is not a one-size-fits-all approach. Cancer type, stage, biomarker profile, and past treatment history all affect eligibility. Physician-led matching is important because of this.

You could qualify if:
Standard chemotherapy and radiation have not been effective in treating your cancer.

You have been informed that immunotherapy is not accessible in your nation.
PD-L1, MSI-H, or certain genetic alterations have been detected in your tumor.
You’re looking for a second opinion on your present course of therapy.
Despite your oncologist’s advice to “watch and wait,” you would like to look into active choices.
You have a cancer kind, such as melanoma, lung, bladder, renal, colorectal, lymphoma, or others, whose response rates to immunotherapy are known.

Immunotherapy eligibility is determined by biomarker testing — specifically PD-L1 expression, tumour mutational burden (TMB), and microsatellite instability (MSI) status. A US oncologist can assess these markers from existing biopsy material without requiring the patient to travel.

Immunotherapy Hospitals in the U.S

Where Immunotherapy Treatment Occurs in the United States Introduction:

The infrastructure for immunotherapy varies among cancer centers. MediPocket does not match patients with the closest facility; rather, it matches them with the facility best suited to their particular cancer type and immunotherapy profile.

Three-column hospital cards:

The MD Anderson Cancer Center

ranked #1 for cancer treatment in the United States. oversees immunotherapy research worldwide and has ongoing studies for over 30 different cancer types. developed a number of checkpoint inhibitor treatments that are currently in use all around the world.

Memorial Sloan Kettering Cancer Centre

home to one of the most cutting-edge immunotherapy research initiatives in the world. Tumor-infiltrating lymphocyte (TIL) treatments, CAR-T protocols, and customized cancer vaccination trials have all been created by MSK.

Johns Hopkins Sidney Kimmel Cancer Center

The origin of checkpoint inhibitor treatment. Johns Hopkins is a reference center for immunotherapy-eligible patients worldwide since its doctors wrote the fundamental research on PD-1 drugs.

MediPocket’s Approach To Immunotherapy

How International Patients Use MediPocket to Get US Immunotherapy Overview:

International patients must undergo clinical evaluation, biomarker matching, institutional selection, and complete coordination in order to get immunotherapy in the United States. MediPocket oversees each stage.

Steps:

1. Submit Your Case

Talk about your diagnosis, pathology reports, current scans, and past medical history. At this point, no travel is necessary.

2. Physician Evaluation

Based on your disease kind and biomarker profile, our medical team evaluates your records to determine your eligibility for immunotherapy.

3. Matching Institutions

You are paired with the US cancer center that offers the best immunotherapy program for your particular situation—not simply a well regarded hospital, but the ideal one.

4. Coordination of Treatment

For your journey to the US, we handle specialist appointments, medical visa letters, airfare, lodging, and on-site assistance.

5. Follow-Up After Treatment

Your US oncology team maintains remote follow-up via MediPocket following treatment, guaranteeing continuity upon your return home.

objective response rate for certain patients with melanoma receiving combination checkpoint inhibitor treatment

20 %

Numerous ongoing US clinical studies are evaluating next-generation immunotherapy combinations that are not yet accessible worldwide.

200000 +

US insurance is not necessary

Prior to making any commitments, MediPocket directly negotiates international patient pricing with all partner institutions.

FAQ:

1. Is it possible for foreign patients to obtain immunotherapy in the United States?

Indeed. Immunotherapy is available to foreign patients as self-paying international patients at US cancer centers. Residency or US insurance are not prerequisites. Prior to making any commitments, MediPocket negotiates direct pricing with partner institutions.

2. How can I find out if I am eligible for immunotherapy?

Tumor mutational burden (TMB), microsatellite instability (MSI) status, and PD-L1 expression levels are the biomarkers used to assess eligibility. Existing biopsy material can be used for these tests. Before any journey is scheduled, a US oncologist can evaluate eligibility virtually.

3. What cancers are treated with immunotherapy in the USA?

A variety of malignancies, such as melanoma, non-small cell lung cancer, bladder cancer, renal cell carcinoma, colorectal cancer with MSI-H status, head and neck cancers, certain lymphomas and leukemias, and liver cancer, are treated by US immunotherapy programs. Subtype and biomarker profile determine eligibility.

4. What distinguishes CAR-T treatment from checkpoint inhibitors?

A variety of cancer forms employ checkpoint inhibitors, which are injectable medications that block the proteins cancer needs to evade immune detection. In order to directly target cancer, CAR-T cell therapy extracts, genetically modifies, and reinfuses a patient’s own T-cells; it is mostly utilized for blood malignancies and some solid tumors.

5. Do I have to go to the United States to begin the immunotherapy process?

Not at all. The biomarker evaluation, specialist matching, and first eligibility assessment are all done remotely. Only once a treatment plan is agreed and an appointment is made is travel necessary.

6. What is the duration of immunotherapy treatment in a US cancer center?

The protocol determines this. Every two to six weeks, some checkpoint inhibitor regimens are given as outpatient infusions. For cell collection, engineering, conditioning, and infusion, CAR-T treatment necessitates a prolonged hospital stay. Based on your particular situation, your US oncologist will verify the timetable.

7. Is immunotherapy accessible online or does it need to be administered in person in the United States?

A physical presence in the United States is necessary for the delivery of immunotherapy. However, before any journey is scheduled, eligibility evaluation, second opinion review, and treatment planning can be finished remotely.

It costs nothing to take the next step.

That response can be insufficient if you have been informed that immunotherapy is not accessible in your nation or that you have few alternatives. Your current records are the first step in a US oncologist evaluation. To find out if you qualify, you don’t need to go.